Radiocontrast nephropathy: Is it dose related or not?

Journal of the Pakistan Medical Association

Volumn 54, Issue 7, 2004, Pages 372-374

  Mekan, S F ^a   Rabbani, M A ^a   Azhar Uddin, M ^a   Ali, S S ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

IOPROMIDE; NONIONIC CONTRAST MEDIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; RADIOCONTRAST NEPHROPATHY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; HUMANS; IOHEXOL; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 4444335888     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1999;19;320:143-9.
2. Rich MW, Crecelius CA. Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 1990;150:1237-42.
3. Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989;320:149-53.
4. Stevens MA, McCullough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999;33:403-11.
5. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
6. Lepor NE. Radiocontrast nephropathy: the dye is not cast. Rev Cardiovasc Med 2000;1:43-54.
7. Soma VR, Cavusoglu E, Vidhun R, et al. Contrast-associated nephropathy. Heart Dis 2002;4:372-9.
8. Lepor NE. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine. Rev Cardiovasc Med 2003;4 (Suppl 1):S15-20.
9. Tepel M, Zidek W. Acetylcysteine and contrast media nephropathy. Curr Opin Nephrol Hypertens 2002;11:503-6.
10. Porter GA. Contrast medium-associated nephropathy. Recognition and management. Invest Radiol 1993;28 (Suppl 4):S11-18.
11. Taliercio CP, Vlietstra RE, Fisher LD, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-4.
12. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The lohexol Cooperative Study. Kidney Int 1995;47:254-61.
13. Martin-Paredero V, Dixon SM, Baker JD, et al. Risk of renal failure after major angiography. Arch Surg 1983;118:1417-20.
14. Cochran ST, Wong WS, Roe DJ. Predicting angiography-induced acute renal function impairment: clinical risk model. Am J Roentgenol 1993;141:1027-33.
15. Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992;182:649-55.
16. D'Elia JA, Gleason RE, Alday M, et al. Nephrotoxicity from angiographic contrast material: a prospective study. Am J Med 1982;72:719-25.
17. Swartz RD, Rubin JE, Leeming BW, et al. Renal failure following major angiography. Am J Med 1978;65:31-7.
18. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. 1994;5:125-37.
19. Harris KG, Smith TP, Cragg AH, et al. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Radiology 1991;179:849-52.
20. Nally JV Jr. Acute renal failure in hospitalized patients. Cleve Clin J Med 2002;69:569-74.
21. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
22. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002;40:299-303.
23. Mitch WE, Walser M. Nutritional therapy for the uremic patients. In: Brenner BM, ed. The Kidney. 5th ed. Philadephia, Pa: W.B. Saunders Company; 1996, pp. 2382-4.
24. Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-52.
25. Rosovsky MA, Rusinek H, Berenstein A, et al. High-dose administration of nonionic contrast media: a retrospective review. Radiology 1996;200:119-22.
26. Kahn JK, Rutherford BD, McConahay DR, et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 1990;120:533-6.